Literature DB >> 4149321

Initial clinical experience with I.C.I. 66.082, a new beta-adrenergic blocking agent, in hypertension.

L Hansson, H Aberg, S Jameson, B Karlberg, R Malmcrona.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4149321     DOI: 10.1111/j.0954-6820.1973.tb19489.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


× No keyword cloud information.
  11 in total

1.  Haemodynamic effects of beta-adrenorecptor blockers in hypertension.

Authors:  B Ablad; B Ljung; R Sannerstedt
Journal:  Drugs       Date:  1976       Impact factor: 9.546

2.  Antihypertensive action of beta-adrenoceptor blockade and the renin-angiotensin system.

Authors:  I Gavras; H Gavras; H R Brunner; C S Liang
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

3.  The effects of atenolol (tenormin) and methyldopa on simple tests of central nervous function.

Authors:  P F Bayliss; S M Duncan
Journal:  Br J Clin Pharmacol       Date:  1975-12       Impact factor: 4.335

4.  The effect of chronic propranolol treatment on overnight plasma levels of anterior pituitary and related hormones.

Authors:  A M Dart; M J Lewis; G V Groom; E M Meek; A H Henderson
Journal:  Br J Clin Pharmacol       Date:  1981-12       Impact factor: 4.335

5.  Controlled study of atenolol in treatment of hypertension.

Authors:  L Hansson; H Aberg; B E Karlberg; A Westerlund
Journal:  Br Med J       Date:  1975-05-17

6.  Once-daily dosing with Atenolol in patients with mild or moderate hypertension.

Authors:  A P Douglas-Jones; J M Cruickshank
Journal:  Br Med J       Date:  1976-04-24

7.  Haemodynamic long-term effects of a new beta-adrenoceptor blocking drug, atenolol (ICI 66082), in essential hypertension.

Authors:  P Lund-Johansen
Journal:  Br J Clin Pharmacol       Date:  1976-06       Impact factor: 4.335

8.  Antihypertensive effect of a non-selective (propranolol) and a cardioselective (metoprolol) beta-adrenoceptor blocking agent at rest and during exercise.

Authors:  N Clausen; T Damsgaard; K Mellemgaard
Journal:  Br J Clin Pharmacol       Date:  1979-04       Impact factor: 4.335

9.  Comparative potency of atenolol and propranolol as beta-adrenergic blocking agents in man.

Authors:  J F De Plaen; A Amery; T Reybrouck
Journal:  Eur J Clin Pharmacol       Date:  1976-09-30       Impact factor: 2.953

10.  A comparison of the antihypertensive effect of atenolol (ICI 66 082) and propranolol.

Authors:  L Hansson; A Westerlund; H Aberg; B E Karlberg
Journal:  Eur J Clin Pharmacol       Date:  1976-03-22       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.